Edgewise Therapeutics, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

   Primary endpoint(s) modified

   Also in this update: Trial completed

   Edgewise Therapeutics, Inc.·Phase 2· NCT05291091· Registry history of NCT05291091 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.